Skip to main content
Premium Trial:

Request an Annual Quote

PlexBio Inks Italian Distribution Deals

NEW YORK (360Dx) – Taiwanese firm PlexBio today announced distribution deals for its products in Italy.

PlexBio and Eurclone Diagnostica inked an exclusive distribution contract to market and sell PlexBio's IntelliPlex 1000 πCode Processor, the PlexBio 100 Fluorescent Analyzer, and several PlexBio CE-marked IVD kits for molecular diagnostics in a targeted segment of the Italian IVD clinical market, PlexBio said.

The PlexBio 100 Fluorescent Analyzer received CE marking in August.

Separately, Euroclone, the parent firm of Euroclone Diagnostica, will be the exclusive distributor of the  IntelliPlex 1000 πCode Processor and the PlexBio 100 Fluorescent Analyzer for the Italian life science research market. The deal also provides for the sale by Euroclone of research reagents based on PlexBio's πCode MicroDisc technology and accessories.

Financial and other terms of the agreements were not disclosed.

The deals provide PlexBio a direct sales and support channel in Italy, the firm said.

"Establishing these distribution relations with Euroclone is a critical first step to PlexBio's European market entry strategy and we are very happy that, together with our partners at Euroclone, we will be able to provide an innovative and powerful workflow solution for two key multiplex testing market segments in Italy," PlexBio COO Stuart Palmer said in a statement.

Earlier this year, PlexBio announced an expansion of its collaboration with Denka to include the codevelopment of a molecular diagnostic platform for infectious disease testing.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.